stella
beta
CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction — Stella
Recruiting
Back to B-cell Acute Lymphoblastic Leukemia trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
Beijing GoBroad Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov